Daily adjusted radiation dose for abdominal and pelvic tumors
Part of Cancer clinical trials.
This trial tests a new way to give radiation therapy for tumors in the belly or pelvis. Doctors will use daily MRI scans to adjust the radiation dose, aiming to better protect nearby organs while still treating the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to care for yourself and be active at least 70% of the time (Karnofsky score of 70 or more).
- You have a tumor in the abdomen or pelvis (either a primary cancer or one that spread there), confirmed by biopsy, and it can be treated with 5 sessions of radiation (SBRT).
- The tumor must be close (within 1 cm) to a dose-limiting organ like the bowel, duodenum, or stomach.
- You can lie still for about 60 minutes for each treatment session.
- You must not have had radiation therapy that overlaps with this treatment area before.
- You must not have any metal in your body that is unsafe for MRI, like certain pacemakers or metal fragments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of giving high-dose radiation therapy to prostate cancer that has spread to nearby lymph nodes. The radiation is given weekly and uses special imaging to target the tumor precisely, which may help control the cancer while limiting side effects.
This trial tests a new way to deliver high-precision radiation to the prostate using daily MRI or CT scans to adjust the treatment based on your exact anatomy. It aims to make radiation more accurate and reduce side effects.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This study tests a new radiation therapy method that uses MRI to adjust your treatment in real time. It is designed for people with bilateral hip replacements who are undergoing standard radiation for localized prostate cancer.
This trial is testing a precise type of radiation therapy (called SBRT) for people with sarcoma in the belly or pelvic area. The goal is to see if this targeted radiation can help shrink or control the tumor before surgery, and it may be an option if you haven't had radiation to that area before.
This Phase 1 study tests an “adaptive” form of focused radiation (SBRT) for cancers that have spread in the abdomen or pelvis. It aims to treat metastatic tumor spots safely while adjusting the plan as needed during treatment.
Hear when a new Pelvic Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.